These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 3128689

  • 1. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ, Wolthers BG, van der Molen JC, van der Slik W, Waterreus RJ, van Spreeken A.
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [Abstract] [Full Text] [Related]

  • 2. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
    Batta AK, Shefer S, Batta M, Salen G.
    J Lipid Res; 1985 Jun; 26(6):690-8. PubMed ID: 4031647
    [Abstract] [Full Text] [Related]

  • 3. Detection of carriers of cerebrotendinous xanthomatosis.
    Koopman BJ, Waterreus RJ, Van den Brekel HW, Wolthers BG.
    Clin Chim Acta; 1986 Jul 30; 158(2):179-85. PubMed ID: 3742821
    [Abstract] [Full Text] [Related]

  • 4. Reduction of urinary bile alcohol excretion and serum cholestanol in patients with cerebrotendinous xanthomatosis after oral administration of deoxycholic acid.
    Wolthers BG, van der Molen JC, Walrecht H, Hesselmans LF.
    Clin Chim Acta; 1990 Dec 14; 193(3):113-8. PubMed ID: 2282689
    [Abstract] [Full Text] [Related]

  • 5. Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.
    Koopman BJ, Wolthers BG, van der Molen JC, Waterreus RJ.
    Clin Chim Acta; 1985 Oct 31; 152(1-2):115-22. PubMed ID: 4053393
    [Abstract] [Full Text] [Related]

  • 6. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
    Shimazu K, Kuwabara M, Yoshii M, Kihira K, Takeuchi H, Nakano I, Ozawa S, Onuki M, Hatta Y, Hoshita T.
    J Biochem; 1986 Feb 31; 99(2):477-83. PubMed ID: 3700361
    [Abstract] [Full Text] [Related]

  • 7. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Tint GS.
    Gastroenterology; 1984 Aug 31; 87(2):276-83. PubMed ID: 6735073
    [Abstract] [Full Text] [Related]

  • 8. Biochemical studies of inherited diseases related to abnormal cholesterol metabolism. I. High-performance liquid chromatographic analysis of bile alcohol glucuronides in cerebrotendinous xanthomatosis.
    Ohshima A, Kuramoto T, Hoshita T.
    Biol Pharm Bull; 1994 May 31; 17(5):721-3. PubMed ID: 7920441
    [Abstract] [Full Text] [Related]

  • 9. Biochemical abnormalities in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Berginer V.
    Dev Neurosci; 1991 May 31; 13(4-5):363-70. PubMed ID: 1817043
    [Abstract] [Full Text] [Related]

  • 10. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
    Salen G, Shefer S, Tint GS, Nicolau G, Dayal B, Batta AK.
    J Clin Invest; 1985 Aug 31; 76(2):744-51. PubMed ID: 4031069
    [Abstract] [Full Text] [Related]

  • 11. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
    Batta AK, Salen G, Shefer S, Tint GS, Batta M.
    J Lipid Res; 1987 Aug 31; 28(8):1006-12. PubMed ID: 3668385
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.
    Wolthers BG, Volmer M, van der Molen J, Koopman BJ, de Jager AE, Waterreus RJ.
    Clin Chim Acta; 1983 Jun 30; 131(1-2):53-65. PubMed ID: 6883710
    [Abstract] [Full Text] [Related]

  • 13. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
    Björkhem I, Buchmann MS, Skrede S.
    Biochim Biophys Acta; 1983 Sep 20; 753(2):220-6. PubMed ID: 6412759
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and structure of 26 (or 27)-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24S,25 xi-pentol isolated from the urine and feces of a patient with sitosterolemia and xanthomatosis.
    Dayal B, Tint GS, Toome V, Batta AK, Shefer S, Salen G.
    J Lipid Res; 1985 Mar 20; 26(3):298-305. PubMed ID: 2985722
    [Abstract] [Full Text] [Related]

  • 15. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment.
    Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Waterreus RJ, Oosterhuis HJ.
    Clin Chim Acta; 1984 Sep 15; 142(1):103-11. PubMed ID: 6478619
    [Abstract] [Full Text] [Related]

  • 16. Assay of intermediates in bile acid biosynthesis using isotope dilution--mass spectrometry: hepatic levels in the normal state and in cerebrotendinous xanthomatosis.
    Björkhem I, Oftebro H, Skrede S, Pedersen JI.
    J Lipid Res; 1981 Feb 15; 22(2):191-200. PubMed ID: 7017048
    [Abstract] [Full Text] [Related]

  • 17. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
    Clarenbach JJ, Lindenthal B, Dotti MT, Federico A, Kelleher JK, von Bergmann K.
    Metabolism; 2005 Mar 15; 54(3):335-44. PubMed ID: 15736111
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis.
    Yasuhara M, Kuramoto T, Hoshita T, Itoga E, Kito S.
    Steroids; 1978 Mar 15; 31(3):333-45. PubMed ID: 663972
    [Abstract] [Full Text] [Related]

  • 20. Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis.
    Kuramoto T, Suemura Y, Kihira K, Hiraoka T, Hoshita T.
    Steroids; 1995 Oct 15; 60(10):709-12. PubMed ID: 8539780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.